Publications
2024
2023
Regulatory Toxicology and Pharmacology 2023; Vol. 143
2022
Biotechnology Bioengineering Journal
2022; p1-32
Journal of Pharmaceutical Innovation
July, 2022
Biotechnology & Genetic Engineering Reviews
Feb., 2022
J Pharm Pharm Sci
April, 2022; Vol. 25; p149-182
Journal of Intellectual Property Law & Practice
April, 2022; Vol. 17, No. 4; p339-349
Subscribe to our Newsletter!
If you would like to receive a complementary e-mail issue, just let us know and we will send you the same. If you want us to speak to your company or organization, please contact us directly.
2020
Journal of Generic Medicine 2020; Vol. 16(2); p64–71
2019
European Intellectual Property Review
2019; Vol. 41, Issue 10; p658-663
European Intellectual Property Review
2019; Vol. 41, Issue 8; p519-525
Patent Linkage: Linking Marketing Approval to the Patent Life without Prejudicing Generics—A Case Study of Pakistan v India and the Rest of the World
2018
International Review of Intellectual Property and Competition Law (IIC)
2018; Vol. 49(6); p700-713
2016
CIPA Journal
Nov., 2016; p46-50
Specialist IP tribunals in Pakistan
CIPA Journal
2016; Vol. 45(8-9); p21-25
Patent infringement proceedings in Pakistan
2015
CIPA Journal
March, 2015; p151-156
Subscribe to our Newsletter!
If you would like to receive a complementary e-mail issue, just let us know and we will send you the same. If you want us to speak to your company or organization, please contact us directly.
2014
CIPA Journal
Oct., 2014; p557-561
Grasping too much? Challenges with pharmaceutical and biotechnology patents for “analog compounds”
2013
CIPA Journal
June, 2013; p327-331
Divergent approaches towards patentability of inventions relating to diagnostics, biomarkers and personalized medicines in various technology-driven economies
Managing Intellectual Property
May, 2013; p117-118
How to avoid compulsory licenses
Managing Intellectual Property
April, 2013; p101
How to avoid non-unity challenges
Managing Intellectual Property
March, 2013; p145
Gene patent practice diverges from the U.S.
Managing Intellectual Property
Feb., 2013; p156
Enhanced protection for process inventions
CIPA Journal
Jan., 2013; p2-3
Pharmaceutical and biotechnology patents meet with higher standards of non-obviousness in Pakistan
2012
Managing Intellectual Property
Dec. 2012-Jan. 2013; p62
Selective species of an earlier disclosed “genus” is patentable
Nature Biotechnology
Dec. 2012; Vol. 30(12); p1-3
Uncertainty over pharmaceutical and biotech product patents in Pakistan
Managing Intellectual Property
Nov. 2012; p76-77
Grant of Markush-style claims clarifies patent scope
Managing Intellectual Property
Oct. 2012; p75
Patent Office follows Canada on plant patentability
Managing Intellectual Property
Sep. 2012; p103-104
New use patents run risk of opposition
2011
CIPA Journal
Vol. 40(10); p633-635
Bio-prospecting: Pakistan patent law treats contribution of indigenous knowledge as ‘non-inventive’
Managing Intellectual Property
IP Focus, 9th Edition; p43-46
Patenting life sciences
CIPA Journal
Aug. 2011; p510-511
Daicel v Celanese: the Pakistan PO's controversial order on the admissibility of the notice 0f opposition
2010
CIPA Journal
Oct. 2010; p606-609
Patent opposition proceedings in Pakistan
CIPA Journal
Vol. 40(10); p633-635
Patentability of selection inventions in Pakistan in the backdrop of practice in the UK and the US
2006
asialaw IP Review
Vol. 3, Issue 4; Oct. 2006; p26-29
Important issues relating to Pakistan
asialaw IP Review
Vol. 3, Issue 1; Jan. 2006; p15-17
Drafting patent claims in Pakistan – an analysis of the conventional and current practices
2005
asialaw IP Review
Vol. 2, Issue 3; July, 2005; p13-14